Skip to main content
Fig. 4 | BMC Complementary Medicine and Therapies

Fig. 4

From: Bioinformatics screening the novel and promising targets of curcumin in hepatocellular carcinoma chemotherapy and prognosis

Fig. 4

Expression, prognosis, and diagnosis of selected genes in hepatocellular carcinoma. A-G The mRNA expression of AURKA, CCNB1, CDK1, TOP2A, CYP2B6, CYP2C9 and CYP3A4 in hepatocellular carcinoma patients’ tumor tissues and adjacent normal tissues. H-N Kaplan-Meier analysis of Overall Survival for hepatocellular carcinoma patients based on the expression of AURKA, CCNB1, CDK1, TOP2A, CYP2B6, CYP2C9 and CYP3A4. O ROC curve analysis for AURKA, CCNB1, CDK1, TOP2A, CYP2B6, CYP2C9 and CYP3A4 in hepatocellular carcinoma. ***p < 0.001, tumor tissues of each stage versus adjacent normal tissues; ###p < 0.001 tumor tissues of stage I versus tumor tissues of stage III

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us